Moreover, HE4 is over-expressed in ovarian cancer, particularly in serous, clear cell and endometroid epithelial ovarian carcinomas [14], and is secreted early in the serum of patients with ovarian cancer [15]. This evidence concerns the gene WFDC2 and ovarian cancer.